Hydrocortisone controlled release formulation
作者： Hiep Huatan , Richard Ross , Martin Whitaker
DOI:
关键词: Delayed release (linguistics) 、 Controlled release 、 Adrenal insufficiency 、 Hydrocortisone 、 Endocrinology 、 Medicine 、 Pharmaceutical formulation 、 Pharmacology 、 Internal medicine
摘要: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from delayed release hydrocortisone, particular such as adrenal insufficiency, inflammatory depression.
google.co.in 参考文章(26)
Ross Richard, Sustained release hydrocortisone treatment ,(2007)
Peter Lütolf, Werner Scheiwe, Reto Maurer, Medicament for treating intestinal diseases ,(2000)
Ruediger Alexowsky, Hans-Ulrich Petereit, Kathrin Nollenberger, Erna Roth, Christian Meier, A process for converting a solid (meth)acrylate copolymer into a dispersed form by means of a dispersing agent ,(2009)
Klaus Dietzel, Ruediger Nave, Florian Abel, Stefan Postius, Antje Brueck-Scheffler, Richter Oliver Von, Klaus Eistetter, Use of ciclesonide for the treatment of inflammatory bowel diseases ,(2004)
Gregory Paul Dittmar, Tony Ryan Cronk, Joseph Michael Amante, Daniel Gary Newby, Pharmaceutical dosage form with multiple coatings ,(2001)
Hélène-Céline Huguet, Antoine Andremont, Colonic delivery using zn/pectin beads with a eudragit coating. ,(2007)
Richard Ross, Amin Rostami-Hodjegan, Geoffrey Tucker, Delayed and sustained drug release ,(2002)
Hiep Huatan, Richard Ross, Martin Whitaker, Treatment of adrenal insufficiency ,(2009)
Mahesh V. Padval, Therapeutic regimens for the treatment of immunoinflammatory disorders ,(2008)